Grifols SA (GRFS) stock
GRFSNasdaqPharmaceutical PreparationsAlso trades as GIFLF, GIFOF, GIKLY
$8.73+0.04 (+0.46%)
Close on Nov 16, 2026Market cap $3.00BP/E 6.7Yield –
Grifols price to sales ratio
The price-to-sales ratio is market cap divided by revenue over the trailing twelve months.
Grifols's price to sales ratio was 0.4× on Nov 11, 2026, against 0.4× a year earlier. Over the last 5 years it ranged from 0.3× to 0.8×, with a median of 0.4×.
Price to Sales Ratio at the end of each year
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| 2026 | Nov 11, 2026 | 0.4× | −0.0 |
| 2025 | Dec 31, 2025 | 0.4× | +0.0 |
| 2024 | Dec 31, 2024 | 0.4× | −0.2 |
| 2023 | Dec 29, 2023 | 0.6× | +0.0 |
| 2022 | Dec 30, 2022 | 0.5× | −0.1 |
| 2021 | Dec 31, 2021 | 0.6× | −0.4 |
| 2020 | Dec 31, 2020 | 1.0× | −0.6 |
| 2019 | Dec 31, 2019 | 1.6× | +0.3 |
| 2018 | Dec 31, 2018 | 1.3× | −0.3 |
| 2017 | Dec 29, 2017 | 1.6× | +0.3 |
| 2016 | Dec 30, 2016 | 1.3× | – |
See a number that looks wrong?